🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
1.050
0.00 (0.00%)
Nov 19, 2026, 9:30 AM EST

ME Therapeutics Holdings Ratios and Metrics

Millions CAD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22
3211869--
Market Cap Growth
-73.04%70.86%---
Enterprise Value
3111768--
Last Close Price
1.054.002.75--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22
PB Ratio
49.4678.7446.94--
P/TBV Ratio
49.4678.7446.94--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22
Debt / Equity Ratio
0.040.05-0.08-1.46
Net Debt / Equity Ratio
-0.79-0.89-1.01-1.16-0.88
Net Debt / EBITDA Ratio
0.331.071.090.62-0.76
Net Debt / FCF Ratio
0.401.232.282.00-0.85
Quick Ratio
3.876.0024.054.410.57
Current Ratio
3.916.1224.454.520.59
Return on Equity (ROE)
-111.03%-80.11%-129.52%-3327.53%-
Return on Assets (ROA)
-69.00%-48.35%-77.65%-157.78%-
Return on Capital Employed (ROCE)
-240.40%-84.30%-93.10%-186.70%212.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22
Earnings Yield
-4.40%-1.01%-1.87%--
FCF Yield
-4.04%-0.91%-0.95%--
Buyback Yield / Dilution
-11.85%-14.17%-55.90%-84.08%-